Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (97)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Trettel, F.
Right arrow Articles by MacDonald, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trettel, F.
Right arrow Articles by MacDonald, M. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 19 2799-2809
© 2000 Oxford University Press

Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells

Flavia Trettel, Dorotea Rigamonti1, Paige Hilditch-Maguire, Vanessa C. Wheeler, Alan H. Sharp2, Francesca Persichetti, Elena Cattaneo1 and Marcy E. MacDonald+

Molecular Neurogenetics Unit, Massachusetts General Hospital, Building 149, 13th Street, Charlestown, MA 02129, USA, 1Institute of Pharmacological Sciences, University of Milano, 20133 Milano, Italy and 2Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA

Lengthening a glutamine tract in huntingtin confers a dominant attribute that initiates degeneration of striatal neurons in Huntington’s disease (HD). To identify pathways that are candidates for the mutant protein’s abnormal function, we compared striatal cell lines established from wild-type and HdhQ111 knock-in embryos. Alternate versions of full-length huntingtin, distinguished by epitope accessibility, were localized to different sets of nuclear and perinuclear organelles involved in RNA biogenesis and membrane trafficking. However, mutant STHdhQ111 cells also exhibited additional forms of the full-length mutant protein and displayed dominant phenotypes that did not mirror phenotypes caused by either huntingtin deficiency or excess. These phenotypes indicate a disruption of striatal cell homeostasis by the mutant protein, via a mechanism that is separate from its normal activity. They also support specific stress pathways, including elevated p53, endoplasmic reticulum stress response and hypoxia, as potential players in HD.

+ To whom correspondence should be addressed: Tel: +1 617 726 5089; Fax: +1 617 726 5735; Email: macdonam@helix.mgh.harvard.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
M. Raspe, J. Gillis, H. Krol, S. Krom, K. Bosch, H. van Veen, and E. Reits
Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity
J. Cell Sci., September 15, 2009; 122(18): 3262 - 3271.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Carnemolla, E. Fossale, E. Agostoni, S. Michelazzi, R. Calligaris, L. De Maso, G. Del Sal, M. E. MacDonald, and F. Persichetti
Rrs1 Is Involved in Endoplasmic Reticulum Stress Response in Huntington Disease
J. Biol. Chem., July 3, 2009; 284(27): 18167 - 18173.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Subramaniam, K. M. Sixt, R. Barrow, and S. H. Snyder
Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity
Science, June 5, 2009; 324(5932): 1327 - 1330.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. del Toro, J. Alberch, F. Lazaro-Dieguez, R. Martin-Ibanez, X. Xifro, G. Egea, and J. M. Canals
Mutant Huntingtin Impairs Post-Golgi Trafficking to Lysosomes by Delocalizing Optineurin/Rab8 Complex from the Golgi Apparatus
Mol. Biol. Cell, March 1, 2009; 20(5): 1478 - 1492.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
D. Zala, E. Colin, H. Rangone, G. Liot, S. Humbert, and F. Saudou
Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons
Hum. Mol. Genet., December 15, 2008; 17(24): 3837 - 3846.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. L. Duennwald and S. Lindquist
Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity
Genes & Dev., December 1, 2008; 22(23): 3308 - 3319.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. L. Benn, T. Sun, G. Sadri-Vakili, K. N. McFarland, D. P. DiRocco, G. J. Yohrling, T. W. Clark, B. Bouzou, and J.-H. J. Cha
Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner
J. Neurosci., October 15, 2008; 28(42): 10720 - 10733.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Paoletti, I. Vila, M. Rife, J. M. Lizcano, J. Alberch, and S. Gines
Dopaminergic and Glutamatergic Signaling Crosstalk in Huntington's Disease Neurodegeneration: The Role of p25/Cyclin-Dependent Kinase 5
J. Neurosci., October 1, 2008; 28(40): 10090 - 10101.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Quintanilla, Y. N. Jin, K. Fuenzalida, M. Bronfman, and G. V. W. Johnson
Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells: POSSIBLE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma} (PPAR{gamma}) IN THE PATHOGENESIS OF HUNTINGTON DISEASE
J. Biol. Chem., September 12, 2008; 283(37): 25628 - 25637.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. M. Kortlever, T. R. Brummelkamp, L. A. van Meeteren, W. H. Moolenaar, and R. Bernards
Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling
Mol. Cancer Res., September 1, 2008; 6(9): 1452 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. N. Savas, A. Makusky, S. Ottosen, D. Baillat, F. Then, D. Krainc, R. Shiekhattar, S. P. Markey, and N. Tanese
Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies
PNAS, August 5, 2008; 105(31): 10820 - 10825.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M.-O. Kim, P. Chawla, R. P. Overland, E. Xia, G. Sadri-Vakili, and J.-H. J. Cha
Altered Histone Monoubiquitylation Mediated by Mutant Huntingtin Induces Transcriptional Dysregulation
J. Neurosci., April 9, 2008; 28(15): 3947 - 3957.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Lim, L. Fedrizzi, M. Tartari, C. Zuccato, E. Cattaneo, M. Brini, and E. Carafoli
Calcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
J. Biol. Chem., February 29, 2008; 283(9): 5780 - 5789.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. S. Atwal, J. Xia, D. Pinchev, J. Taylor, R. M. Epand, and R. Truant
Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity
Hum. Mol. Genet., November 1, 2007; 16(21): 2600 - 2615.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Rigamonti, D. Bolognini, C. Mutti, C. Zuccato, M. Tartari, F. Sola, M. Valenza, A. G. Kazantsev, and E. Cattaneo
Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators
J. Biol. Chem., August 24, 2007; 282(34): 24554 - 24562.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. L. Lumsden, T. L. Henshall, S. Dayan, M. T. Lardelli, and R. I. Richards
Huntingtin-deficient zebrafish exhibit defects in iron utilization and development
Hum. Mol. Genet., August 15, 2007; 16(16): 1905 - 1920.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. L. Anne, F. Saudou, and S. Humbert
Phosphorylation of Huntingtin by Cyclin-Dependent Kinase 5 Is Induced by DNA Damage and Regulates Wild-Type and Mutant Huntingtin Toxicity in Neurons
J. Neurosci., July 4, 2007; 27(27): 7318 - 7328.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Zuccato, N. Belyaev, P. Conforti, L. Ooi, M. Tartari, E. Papadimou, M. MacDonald, E. Fossale, S. Zeitlin, N. Buckley, et al.
Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease
J. Neurosci., June 27, 2007; 27(26): 6972 - 6983.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Sadri-Vakili, B. Bouzou, C. L. Benn, M.-O. Kim, P. Chawla, R. P. Overland, K. E. Glajch, E. Xia, Z. Qiu, S. M. Hersch, et al.
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models
Hum. Mol. Genet., June 1, 2007; 16(11): 1293 - 1306.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. P. Dompierre, J. D. Godin, B. C. Charrin, F. P. Cordelieres, S. J. King, S. Humbert, and F. Saudou
Histone Deacetylase 6 Inhibition Compensates for the Transport Deficit in Huntington's Disease by Increasing Tubulin Acetylation
J. Neurosci., March 28, 2007; 27(13): 3571 - 3583.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Rockabrand, N. Slepko, A. Pantalone, V. N. Nukala, A. Kazantsev, J. L. Marsh, P. G. Sullivan, J. S. Steffan, S. L. Sensi, and L. M. Thompson
The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis
Hum. Mol. Genet., January 1, 2007; 16(1): 61 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. del Toro, J. M. Canals, S. Gines, M. Kojima, G. Egea, and J. Alberch
Mutant huntingtin Impairs the Post-Golgi Trafficking of Brain-Derived Neurotrophic Factor But Not Its Val66Met Polymorphism
J. Neurosci., December 6, 2006; 26(49): 12748 - 12757.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Milakovic, R. A. Quintanilla, and G. V. W. Johnson
Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells: FUNCTIONAL CONSEQUENCES
J. Biol. Chem., November 17, 2006; 281(46): 34785 - 34795.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. M. A. Oliveira, S. Chen, S. Almeida, R. Riley, J. Goncalves, C. R. Oliveira, M. R. Hayden, D. G. Nicholls, L. M. Ellerby, and A. C. Rego
Mitochondrial-Dependent Ca2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors
J. Neurosci., October 25, 2006; 26(43): 11174 - 11186.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Shibata, T. Lu, T. Furuya, A. Degterev, N. Mizushima, T. Yoshimori, M. MacDonald, B. Yankner, and J. Yuan
Regulation of Intracellular Accumulation of Mutant Huntingtin by Beclin 1
J. Biol. Chem., May 19, 2006; 281(20): 14474 - 14485.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Arango, S. Holbert, D. Zala, E. Brouillet, J. Pearson, E. Regulier, A. K. Thakur, P. Aebischer, R. Wetzel, N. Deglon, et al.
CA150 expression delays striatal cell death in overexpression and knock-in conditions for mutant huntingtin neurotoxicity.
J. Neurosci., April 26, 2006; 26(17): 4649 - 4659.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. Pal, F. Severin, B. Lommer, A. Shevchenko, and M. Zerial
Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease.
J. Cell Biol., February 13, 2006; 172(4): 605 - 618.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Pardo, E. Colin, E. Regulier, P. Aebischer, N. Deglon, S. Humbert, and F. Saudou
Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421
J. Neurosci., February 1, 2006; 26(5): 1635 - 1645.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Jin, M. LaFevre-Bernt, Y. Sun, S. Chen, J. Gafni, D. Crippen, A. Logvinova, C. A. Ross, D. A. Greenberg, and L. M. Ellerby
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease
PNAS, December 13, 2005; 102(50): 18189 - 18194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. H. Anborgh, C. Godin, M. Pampillo, G. K. Dhami, L. B. Dale, S. P. Cregan, R. Truant, and S. S. G. Ferguson
Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-binding Protein Optineurin
J. Biol. Chem., October 14, 2005; 280(41): 34840 - 34848.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
I. S. Seong, E. Ivanova, J.-M. Lee, Y. S. Choo, E. Fossale, M. Anderson, J. F. Gusella, J. M. Laramie, R. H. Myers, M. Lesort, et al.
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
Hum. Mol. Genet., October 1, 2005; 14(19): 2871 - 2880.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Milakovic and G. V. W. Johnson
Mitochondrial Respiration and ATP Production Are Significantly Impaired in Striatal Cells Expressing Mutant Huntingtin
J. Biol. Chem., September 2, 2005; 280(35): 30773 - 30782.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Y. S. Choo, G. V.W. Johnson, M. MacDonald, P. J. Detloff, and M. Lesort
Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release
Hum. Mol. Genet., July 15, 2004; 13(14): 1407 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Q. Ruan, M. Lesort, M. E. MacDonald, and G. V.W. Johnson
Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway
Hum. Mol. Genet., April 1, 2004; 13(7): 669 - 681.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Prince, S. Carreira, K. W. Vance, A. Abrahams, and C. R. Goding
Tbx2 Directly Represses the Expression of the p21WAF1 Cyclin-Dependent Kinase Inhibitor
Cancer Res., March 1, 2004; 64(5): 1669 - 1674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gines, E. Ivanova, I.-S. Seong, C. A. Saura, and M. E. MacDonald
Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells
J. Biol. Chem., December 12, 2003; 278(50): 50514 - 50522.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. E. MacDonald
Huntingtin: Alive and Well and Working in Middle Management
Sci. Signal., November 4, 2003; 2003(207): pe48 - pe48.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Xia, D. H. Lee, J. Taylor, M. Vandelft, and R. Truant
Huntingtin contains a highly conserved nuclear export signal
Hum. Mol. Genet., June 15, 2003; 12(12): 1393 - 1403.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. G. Dirac and R. Bernards
Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53
J. Biol. Chem., March 28, 2003; 278(14): 11731 - 11734.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Gines, I. S. Seong, E. Fossale, E. Ivanova, F. Trettel, J. F. Gusella, V. C. Wheeler, F. Persichetti, and M. E. MacDonald
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
Hum. Mol. Genet., March 1, 2003; 12(5): 497 - 508.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. Fossale, V. C. Wheeler, V. Vrbanac, L.-A. Lebel, A. Teed, J. S. Mysore, J. F. Gusella, M. E. MacDonald, and F. Persichetti
Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice
Hum. Mol. Genet., September 15, 2002; 11(19): 2233 - 2241.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Luthi-Carter, S. A. Hanson, A. D. Strand, D. A. Bergstrom, W. Chun, N. L. Peters, A. M. Woods, E. Y. Chan, C. Kooperberg, D. Krainc, et al.
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain
Hum. Mol. Genet., August 15, 2002; 11(17): 1911 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. C. Wheeler, C.-A. Gutekunst, V. Vrbanac, L.-A. Lebel, G. Schilling, S. Hersch, R. M. Friedlander, J. F. Gusella, J.-P. Vonsattel, D. R. Borchelt, et al.
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice
Hum. Mol. Genet., March 1, 2002; 11(6): 633 - 640.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. R. Brummelkamp, R. M. Kortlever, M. Lingbeek, F. Trettel, M. E. MacDonald, M. van Lohuizen, and R. Bernards
TBX-3, the Gene Mutated in Ulnar-Mammary Syndrome, Is a Negative Regulator of p19ARF and Inhibits Senescence
J. Biol. Chem., February 15, 2002; 277(8): 6567 - 6572.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
S Davies and D B Ramsden
Huntington's disease
Mol. Pathol., December 1, 2001; 54(6): 409 - 413.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C. Zuccato, A. Ciammola, D. Rigamonti, B. R. Leavitt, D. Goffredo, L. Conti, M. E. MacDonald, R. M. Friedlander, V. Silani, M. R. Hayden, et al.
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Science, July 20, 2001; 293(5529): 493 - 498.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.